Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03180515 · ClinicalTrials.gov registry record · NA
Neural and Kinematic Features of Freezing of Gait for Adaptive Neurostimulation
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03180515: Completed NA study, sponsored by Stanford University.
NCT03180515 is a NA study that has completed, run by Stanford University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03180515, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Continuous deep brain stimulation (cDBS) is an established therapy for the major motor signs in Parkinson's disease, however some patients find that it does not adequately treat their freezing of gait (FOG). Currently, cDBS is limited to "open-loop" stimulation,without real-time adjustment to the patient's state of activity, fluctuations and types of motor symptoms, medication dosages, or neural markers of the disease. The purpose of this study is to determine if an adaptive DBS system,responding to patient specific, clinically relevant neural or kinematic feedback related to FOG, is more effective than continuous DBS on the motor Unified Parkinson's Disease Rating Scale (UPDRS III) and gait measures of PD.
Interventions
- DEVICE Activa PC+S Neurostimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2018-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03180515
The ClinicalTrials.gov registry entry for NCT03180515 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Activa PC+S Neurostimulator is the first listed.
NCT03180515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03180515 about?
NCT03180515 is a clinical study titled "Neural and Kinematic Features of Freezing of Gait for Adaptive Neurostimulation". Continuous deep brain stimulation (cDBS) is an established therapy for the major motor signs in Parkinson's disease, however some patients find that it does not adequately treat their freezing of gait (FOG). Currently, cDBS is limited to "open-loop" stimulation,without real-time adjustment to the pa...
What is the current status of trial NCT03180515?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-05-15. Estimated completion is 2018-10-31.
What interventions are being tested in trial NCT03180515?
The interventions under investigation include: Activa PC+S Neurostimulator (DEVICE).
Who is sponsoring clinical trial NCT03180515?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.